These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7323739

  • 1. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO, Forshell GP, Fritjofsson A, Norlén BJ.
    Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP.
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
    [Abstract] [Full Text] [Related]

  • 3. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ, Andersson SB, Björk P, Gunnarsson PO, Fritjofsson A.
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
    Kirdani RY, Karr JP, Murphy GP, Sandberg AA.
    N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
    Gunnarsson PO, Andersson SB, Johansson SA, Nilsson T, Plym-Forshell G.
    Eur J Clin Pharmacol; 1984 Aug; 26(1):113-9. PubMed ID: 6714283
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H, Shida K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [Abstract] [Full Text] [Related]

  • 9. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W, Wegner G.
    Scand J Urol Nephrol Suppl; 1980 Mar; 55():147-9. PubMed ID: 6938018
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of estramustine phosphate.
    Gunnarsson PO, Forshell GP.
    Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
    [No Abstract] [Full Text] [Related]

  • 13. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A, Norlén BJ, Högberg B, Rajalakshmi M, Cekan SZ, Diczfalusy E.
    Scand J Urol Nephrol; 1981 Jun; 15(1):37-44. PubMed ID: 6787701
    [Abstract] [Full Text] [Related]

  • 14. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
    Walz PH, Björk P, Gunnarsson PO, Edman K, Hartley-Asp B.
    Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
    [Abstract] [Full Text] [Related]

  • 15. Accumulation of estramustine and estromustine in adipose tissue of rats and humans.
    Gunnarsson PO, Andersson SB, Sandberg AA, Ellman M.
    Cancer Chemother Pharmacol; 1991 Sep; 28(5):361-4. PubMed ID: 1914079
    [Abstract] [Full Text] [Related]

  • 16. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A, Catane R, Murphy GP.
    Cancer Treat Rep; 1977 Sep; 61(2):307-10. PubMed ID: 872134
    [Abstract] [Full Text] [Related]

  • 17. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA.
    Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract] [Full Text] [Related]

  • 18. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R, Kaufman J, Mittelman A, Murphy GP.
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [Abstract] [Full Text] [Related]

  • 19. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 20. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F, Kisbenedek L.
    Int Urol Nephrol; 1975 Oct; 7(2):135-40. PubMed ID: 1102475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.